A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma

Full Title

OstEvo Osteosarcoma Evolves

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Damon Reed’s office at 347-971-4412.

Protocol

25-257

Phase

Phase II (phase 2)

Disease Status

Newly Diagnosed & Relapsed/Refractory

Investigator

Damon R. Reed

Co-Investigators

The Asmin Tulpule Lab

Diseases

Primary Bone › Osteosarcoma
Sarcomas › Osteosarcoma

Locations

Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau

ClinicalTrials.gov ID

NCT07477457

ClinicalTrials.gov

Visit ClinicalTrials.gov for full clinical trial description